- Trichomonas vaginalis is a parasite that causes trichomoniasis, a sexually transmitted infection. To detect it, nucleic acid amplification tests (NAATs) are used, which are more sensitive and specific than culture or wet mount1. One type of NAAT is transcription-mediated amplification (TMA), which can detect T. vaginalis RNA from different specimens, such as urine, swabs, or vaginal/endocervical samples231. TMA is an in vitro test that uses the PANTHER System2.
Learn more:✕This summary was generated using AI based on multiple online sources. To view the original source information, use the "Learn more" links.Because they are more sensitive than culture or wet mount, nucleic acid amplification tests (NAATs) have been recommended to detect trichomoniasis. 4,6 Among women in a variety of clinical settings, transcription-mediated amplification (TMA, a type of NAAT) is both sensitive (>95%) and specific (>93%) for T vaginalis with many specimen types, including urine and vaginal/endocervical swabs. 10,11 Among male attendees of sexually...
testdirectory.questdiagnostics.com/test/test-guide…The APTIMA Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the PANTHER System.testguide.labmed.uw.edu/public/view/TRICADTrichomonas vaginalis RNA, Qualitative, TMA, Males - The Trichomonas vaginalis RNA, Qualitative Transcription- Mediated Amplification, Males assay is a nucleic acid amplification test that uses TMA for detection of T. vaginalis RNA in male urethral swabs or urine. It is used in the screening and diagnosis of trichomoniasis [1].
testdirectory.questdiagnostics.com/test/test-detail/… The laboratory diagnosis of Trichomonas vaginalis - PMC
Trichomonas vaginalis is a parasitic protozoan that infects the urogenital tract of both women and men worldwide. Trichomoniasis, which is caused by T vaginalis, is the most common …
See results only from pmc.ncbi.nlm.nih.govRapid Diagnosis of Trichomo…
The AmpliVue™ Trichomonas Assay (Quidel) is a new FDA cleared rapid test …
Diagnosis and Management …
Trichomonas vaginalis is likely the most prevalent nonviral sexually transmitted …
Trichomoniasis - Diagnosis & treatment - Mayo Clinic
May 17, 2022 · Tests include a rapid antigen test and nucleic acid amplification test. If you have trichomoniasis, your provider may also do tests for other sexually transmitted infections (STIs) …
Trichomonas vaginalis, Nucleic Acid Amplification, Varies - Mayo …
Molecular methods, such as the Aptima T vaginalis assay, offer high sensitivity and specificity for detection of trichomoniasis. The Aptima test utilizes target capture, transcription-mediated …
Trichomonas amplified probe - Allina Health Laboratory
Trichomonas vaginalis is the most common curable sexually transmitted disease (STD) agent in the U.S. It causes vaginitis, urethritis, pelvic inflammatory disease, preterm births, low-birth …
Trichomonas vaginalis RNA, Qualitative, TMA - Quest Diagnostics
- 1 vaginal swab in Aptima® Transport Tubeor 1 endocervical swab in Aptima® Transport Tube or 2 mL female or male urine in Aptima® Transport Tube
Trichomoniasis - Symptoms & causes - Mayo Clinic
May 17, 2022 · In women, trichomoniasis can cause a foul-smelling vaginal discharge, genital itching and painful urination. Men who have trichomoniasis typically have no symptoms. …
Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal …
The AmpliVue™ Trichomonas Assay (Quidel) is a new FDA cleared rapid test for qualitative detection of Trichomonas vaginalis (TV) DNA in female vaginal specimens. The assay is based …
TVRNA - Overview: Trichomonas vaginalis, Nucleic Acid …
Detecting Trichomonas vaginalis in urine, cervical/endocervical or vaginal specimen types. Transcription-Mediated Amplification.
How to diagnose and manage Trichomonas vaginalis
Jul 3, 2024 · Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs.
Diagnosis and Management of Trichomonas vaginalis: Summary …
Apr 22, 2022 · Trichomonas vaginalis is likely the most prevalent nonviral sexually transmitted infection, affecting an estimated 3.7 million women and men in the United States.
Related searches for Trichomonas Vaginalis Amplif
Skip to content
